90 related articles for article (PubMed ID: 7117956)
1. [Lung injury due to gold therapy].
Shapira D; Lorber M; Rubin A
Harefuah; 1982 Apr; 102(7):284-5. PubMed ID: 7117956
[No Abstract] [Full Text] [Related]
2. Pulmonary injury induced by gold salts treatment.
Schapira D; Nahir M; Scharf Y
Med Interne; 1985; 23(4):259-63. PubMed ID: 2935924
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary side effects of gold treatment].
Reinicke C
Z Gesamte Inn Med; 1981 Dec; 36(24):969-72. PubMed ID: 7336798
[TBL] [Abstract][Full Text] [Related]
4. [Gold-induced fibrosing alveolitis].
Costabel U; Schmitz-Schumann M; Guzman J; Stierle H; Reinbold WD; Matthys H
Dtsch Med Wochenschr; 1985 Jul; 110(30):1162-6. PubMed ID: 3874760
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic pulmonary fibrosis.
Jackson LK
Clin Chest Med; 1982 Sep; 3(3):579-92. PubMed ID: 6751672
[No Abstract] [Full Text] [Related]
6. Gold-induced pneumonitis.
Slingerland R; Hoogsteden HC; Adriaansen HJ; van der Kwast TH; Hilvering C
Respiration; 1987; 52(3):232-6. PubMed ID: 3438585
[TBL] [Abstract][Full Text] [Related]
7. Symposium: Interstitial lung disease.
Eur J Respir Dis Suppl; 1983; 126():61-76. PubMed ID: 6586455
[No Abstract] [Full Text] [Related]
8. Interstitial-pneumonitis an allergic reaction to gold treatment?
Hellebrand J; Buytendijk HJ; Maesen F
Acta Tuberc Pneumol Belg; 1979; 70(3-4):203-14. PubMed ID: 122304
[No Abstract] [Full Text] [Related]
9. [Pulmonary fibrosis: course, treatment and prognosis].
Tybusz R; Sluszkiewicz-Potaz Z; Ruszel KB
Pol Tyg Lek; 1973 Sep; 28(35):1363-6. PubMed ID: 4784372
[No Abstract] [Full Text] [Related]
10. [Hypersensitivity reactions of the lung to nitrofurantoin].
Müller U; Abbühl K; Bisig J; Baumgartner H; Mühlberger F; Scherrer M; Hoigné R
Schweiz Med Wochenschr; 1970 Dec; 100(51):2206-12. PubMed ID: 5525043
[No Abstract] [Full Text] [Related]
11. Diffuse lung changes associated with gold therapy.
Sepuya SM; Grzybowski S; Burton JD; Clement JG
Can Med Assoc J; 1978 Apr; 118(7):816-8. PubMed ID: 638914
[No Abstract] [Full Text] [Related]
12. [What is safe in the therapy of alveolitis and lung fibrosis?].
Lanser K; von Wichert P
Internist (Berl); 1984 Dec; 25(12):735-40. PubMed ID: 6394536
[No Abstract] [Full Text] [Related]
13. Pharmacological strategies in the idiopatic pulmonary fibrosis of children.
Rigante D; Stabile A
Minerva Pediatr; 2004 Apr; 56(2):161-5. PubMed ID: 15249900
[TBL] [Abstract][Full Text] [Related]
14. [Desquamative interstitial pneumonia].
Hou J; Li WH
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Apr; 7(2):113-6. PubMed ID: 6489046
[No Abstract] [Full Text] [Related]
15. [Interstitial lung diseases].
Strausz J; Schweiger O
Prax Klin Pneumol; 1985 Sep; 39(9):320-3. PubMed ID: 4059175
[No Abstract] [Full Text] [Related]
16. Idiopathic pulmonary fibrosis.
Balamugesh T; Behera D
J Assoc Physicians India; 2007 May; 55():363-70. PubMed ID: 17844698
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of diffuse interstitial fibrosis].
Duroux P; Simonneau G; Cerrina J; Salmona JP
Rev Prat; 1980 Nov; 30(49):3393-4. PubMed ID: 7444291
[No Abstract] [Full Text] [Related]
18. Case 3: Assessment: systemic illness and the chest.
Dinwiddie R
Paediatr Respir Rev; 2000 Mar; 1(1):82. PubMed ID: 16270419
[No Abstract] [Full Text] [Related]
19. Fibrosing alveolitis: a report of 61 cases seen over the past five years.
Jindal SK; Malik SK; Deodhar SD; Sharma BK
Indian J Chest Dis Allied Sci; 1979; 21(4):174-9. PubMed ID: 549853
[No Abstract] [Full Text] [Related]
20. [Diffuse pulmonary fibrosis (fibrosing alveolitis) Current concepts].
García Velázquez P; Selman Lama M
Prensa Med Mex; 1976; 41(3-4):66-70. PubMed ID: 785443
[No Abstract] [Full Text] [Related]
[Next] [New Search]
